New Discovery: High Cholesterol Linked to Brain Damage in Multiple Sclerosis

In a groundbreaking study published in Cell Stem Cell, researchers from the University of Colorado Anschutz Medical Campus and the University of Cambridge have shed light on a new mechanism behind the progression of progressive multiple sclerosis (MS). They discovered that increased cholesterol production can be harmful to brain cells in people with MS, potentially worsening the disease by damaging the nervous system.

Understanding the Link Between Cholesterol and MS

The research team developed a unique model using lab-grown brain-like cells derived from skin cells of MS patients. This innovative approach allowed them to observe a problem with how these cells utilize energy, leading to excessive cholesterol production. This buildup of cholesterol creates harmful substances that damage nerve cells, exacerbating the damage seen in progressive MS.

Statins: A Potential New Treatment Option?

Interestingly, the researchers found that simvastatin, a commonly used cholesterol-lowering drug, can help mitigate this harmful process. Simvastatin improved the energy management of the brain-like cells, creating a healthier environment and potentially slowing down the progression of MS.

“Cholesterol metabolism has been extensively investigated in the context of cardiovascular disease and cancer,” said Angelo D’Alessandro, PhD, professor of biochemistry and molecular genetics at the University of Colorado School of Medicine and co-senior author of the study. “Our findings suggest that these drugs could be repurposed in the treatment of MS.”

Cellular Senescence and MS Progression

This discovery highlights the crucial role of cellular senescence, a state of cellular aging, in the development of MS. The study confirmed the link between cellular senescence and dysmetabolism – problems with how cells use energy. It also emphasized that managing fats, including cholesterol, is essential for proper cell communication and function.

Hope for the Future of MS Treatment

This groundbreaking research offers a new avenue for developing treatments for MS. By targeting cholesterol metabolism, scientists can potentially reduce nerve damage and slow down the progression of this debilitating disease. This innovative use of patient-derived cells has paved the way for a deeper understanding of MS and provides hope for new therapies in the future.

Learn more about MS research and support organizations by visiting the National Multiple Sclerosis Society website: https://www.nationalmssociety.org/